Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aurinia Pharmaceuticals
Biotech
After hunt for buyer fails, Aurinia lays off 25%, drops R&D
Aurinia searched hard for a buyer, but, faced with a lack of offers, the biotech has resorted to trimming its workforce and cleaning out its pipeline.
James Waldron
Feb 15, 2024 8:25am
Aurinia pays $7M for 2 preclinical assets after January FDA nod
Aug 17, 2021 11:56am
Aurinia ditches would-be Restasis rival after phase 2/3 fail
Nov 2, 2020 5:05pm
Aurinia soars as phase 3 lupus study hits primary endpoint
Dec 5, 2019 7:30am